Simon Dumesnil

Simon Dumesnil

Director/Board Member en PASITHEA THERAPEUTICS CORP. .

Fortuna: 18 125 $ al 31/03/2024

47 años
Finance
Consumer Services

Perfil

Simon Dumesnil is an Independent Director at Pasithea Therapeutics Corp.
and a Director & Managing Partner at Dunraven Capital Partners Ltd.
He was a Director at Lehman Brothers International, Inc. from 2003 to 2008 and at Lehman Brother Holding, Inc. from 2008 to 2009.
He was also the Chief Investment Officer at Bluestone Capital Management Ltd.
from 2009 to 2010.
From 2013 to 2018, he served as the MD & Head-Structured Financing Group Americas at UBS Securities LLC.
Mr. Dumesnil received his undergraduate degree from École des Hautes Études Commerciales de Paris and his graduate degree from Bayes Business School.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
23/03/2024 2 500 ( 0.24% ) 18 125 $ 31/03/2024

Cargos activos de Simon Dumesnil

EmpresasCargoInicio
PASITHEA THERAPEUTICS CORP. Director/Board Member 01/04/2021
Dunraven Capital Partners Ltd. Director/Board Member -
Todos los cargos activos de Simon Dumesnil

Antiguos cargos conocidos de Simon Dumesnil.

EmpresasCargoFin
Corporate Officer/Principal 01/01/2018
Chief Investment Officer 01/01/2010
Lehman Brother Holding, Inc. Director/Board Member 01/01/2009
Lehman Brothers Special Financing, Inc. Director/Board Member 01/01/2009
Lehman Brothers International, Inc. Director/Board Member 01/01/2008
Ver el detalle de la experiencia de Simon Dumesnil.

Formación de Simon Dumesnil.

École des Hautes Études Commerciales de Paris Undergraduate Degree
Bayes Business School Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Simon Dumesnil.

Relaciones

100 +

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas7

Finance

Finance

Lehman Brothers International, Inc.

Lehman Brothers Special Financing, Inc.

Finance

Pasithea Therapeutics Corp.

Dunraven Capital Partners Ltd.

Lehman Brother Holding, Inc.

Ver las conexiones de la empresa